Analysis of relative mRNA expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO was performed on PBMCs samples from 95 patients six months after the first MI and 24 healthy controls. This evidence concerns the gene CDKN1A and myocardial infarction.